However, despite encouraging early laboratory findings, its clinical development was discontinued in 2007 after failing to demonstrate significant weight-loss efficacy in large-scale human trials
Furthermore, Netherlands studies have indicated that this peptide can assist in reducing pain
Modern therapeutic options include intratendinous injections of substances believed to inhibit neovascularization, such as corticosteroids (which can cause collagen sclerosis and long-term damage to the tendon), or of substances that relieve pain by other pathways (acupuncture, extracorporeal shock wave therapy [ESWT]) or that stimulate tendon repair (platelet-rich plasma [PRP]) [12,13,14,15]
It is a beneficial drug to most of the common disorders like cardiovascular disorders, diabetes, anemia, hyperhomocysteinemia and degenerative disorders
Further, subcutaneous injection of other small peptides is frequently associated with transient local tenderness, swelling, and bruising